Lung Ultrasound B-lines and Serum KL-6 Correlate with the Severity of Idiopathic Inflammatory Myositis-associated Interstitial Lung Disease
Overview
Authors
Affiliations
Objective: Idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) significantly increases morbidity and mortality. Lung ultrasound B-lines and Krebs von den Lungen-6 (KL-6) are identified as new sonographic and serum markers of ILD, respectively. The aim of our work was to assess the role of B-lines and KL-6 as markers of the severity of IIM-ILD. For this purpose, the correlation among B-lines score, serum KL-6 levels, high-resolution CT (HRCT) score, and pulmonary function tests were investigated in IIM-ILD patients.
Methods: Thirty-eight patients with IIM-ILD underwent chest HRCT scans, lung ultrasound and pulmonary function tests (independently performed within 1 week) examination. To assess severity and extent of ILD at HRCT, the Warrick score was used. The B-lines score denoting the extension of ILD was calculated by summing the number of B-lines on a total of 50 scanning sites. Serum KL-6 levels (U/ml) was measured by chemiluminescent enzyme immunoassay.
Results: A significant correlation was found between the B-lines score and serum KL-6 levels (r = 0.43, P < 0.01), and between the Warrick score and serum KL-6 levels (r = 0.45, P < 0.01). A positive correlation between B-lines score and the Warrick score (r = 0.87, P < 0.0001) was also confirmed. Both B-lines score and KL-6 levels inversely correlated to diffusion capacity for carbon monoxide (r = -0.77, P < 0.0001 and r = -0.42, P < 0.05, respectively) and total lung capacity (r = -0.73, P < 0.0001 and r = -0.36, P < 0.05, respectively). Moreover, B-lines correlated inversely with forced vital capacity (r = -0.73, P < 0.0001), forced expiratory volume in 1 s (r = -0.69, P < 0.0001).
Conclusion: B-lines score and serum KL-6 levels correlate with HRCT findings and pulmonary function tests, supporting their use as measures of IIM-ILD severity.
Wang Y, Chen S, Zheng S, Zhou Z, Zhang W, Du G Arthritis Res Ther. 2024; 26(1):164.
PMID: 39294670 PMC: 11409780. DOI: 10.1186/s13075-024-03399-2.
Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.
Cao H, Huang J, Chang J, Zhu Y, Liang J, Sun C J Transl Int Med. 2023; 11(1):46-56.
PMID: 37533847 PMC: 10393057. DOI: 10.2478/jtim-2022-0029.
Zhou A, Tang H, Peng W, Wang Y, Tang X, Yang H Front Immunol. 2023; 14:1098602.
PMID: 37409133 PMC: 10318146. DOI: 10.3389/fimmu.2023.1098602.
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
Pugashetti J, Khanna D, Kazerooni E, Oldham J Immunol Allergy Clin North Am. 2023; 43(2):411-433.
PMID: 37055096 PMC: 10584384. DOI: 10.1016/j.iac.2023.01.012.
Wang Y, Xie X, Zheng S, Du G, Chen S, Zhang W Front Med (Lausanne). 2023; 9:1066111.
PMID: 36590969 PMC: 9798453. DOI: 10.3389/fmed.2022.1066111.